CERC (Cardiovascular European Research Center)

🚨 New Publication Alert! 🚨 CERC (Cardiovascular European Research Center) is thrilled to announce the publication of a pooled patient-level data analysis from the SENIOR and POEM trials in the European Heart Journal Open. The analysis focused on the safety of one-month dual antiplatelet therapy (DAPT) following the implantation of a biodegradable-polymer everolimus-eluting stent (EES) in patients at high risk of bleeding (HBR). The results? HBR patients receiving biodegradable-polymer EES had few ischemic and bleeding events when treated with just one month of DAPT, demonstrating that this shorter duration is safe for patients with elevated bleeding risks. These findings represent a significant advancement in optimizing treatment strategies for patients at risk, improving safety and efficiency in stent implantation protocols. 🫀 This initiative was led by Drs. Olivier Varenne, Giulio Stefanini, Carlo Andrea Pivato, Daniele Giacoppo, and Dragica Paunovic, and was supported by a grant from Boston Scientific.🫀 Read more about the study in the European Heart Journal Open. Rafael Cavalcante, MD, PhD Emile Mehanna, MD, FACC, Marta Bande MD FSCAI, Marie-Claude Morice #Cardiology #ClinicalResearch #Stents #Synergy #DAPT #CERC #ESC #HeartHealth #POEMTrial #SENIORTrial #HBR #InterventionalCardiology #PatientSafety

🚨 First European implantation of the Corheart 6 LVAS system 🚨 The CERC team is proud to congratulate the outstanding team at Medizinische Universität Wien for the successful first European implantation of the Corheart 6 Left Ventricular Assist System (LVAS). This innovative device, developed by Shenzhen Core Medical Technology Co., Ltd in China, provides vital mechanical support to patients with heart failure. While previously tested in China, this is the first implantation in Europe, with the patient continuing to recover well 3 months post-procedure! Special recognition goes to Prof. Daniel Zimpfer, principal investigator (PI) and Chair of the EACTS Heart Failure Task Force, alongside co-investigator Dr. Julia Riebandt. We also extend our thanks to Prof. Potapov Evgenij, the coordinating Principal Investigator, who traveled from Berlin to support the Vienna team during this milestone procedure. At CERC, we are honored to witness and support such advances in cardiac surgery that push the boundaries of healthcare innovation. Pieter Smits, Julie FAURE, Pavel Dublin, PHANI KRISHNA KONDAMUDI #Cardiology #HeartFailure #MedicalInnovation #HealthcareInnovation

NETROD Study Meeting: Advancing Medical Innovation Together   We were excited to gather with esteemed colleagues for the latest meeting on the NETROD study, sponsored by Shanghai Golden Leaf MedTech.    The collaborative spirit in the room was inspiring, as we worked together to drive forward the innovations that will shape the future of healthcare.    A big thank you to Golden Leaf (BRATTEA) MedTech team, Yanfei Yang, Mingdong Zhang, Yazhuo Gong for their unwavering support, and to all the participants who are making this study a reality! Carine Bikai, Ute Windhoevel, Marie-Claude Morice, Pieter Smits, Felix Mahfoud, Thomas De Beenhouwer, Flavio Ribichini, Sebastian Ewen, Joachim Weil, MD, Lucas Lauder, Atul Pathak, Konstantinos Tsioufis, Miguel Camafort-Babkowski MD PhD FEFIM FSIAC, Agnieszka Olszanecka, Panagiotis Xaplanteris, Joost Daemen, IVAN J NÚÑEZ GIL. #NETRODStudy #MedTechInnovation #PatientCare #ESCCongress

#ESC2024 CERC (Cardiovascular European Research Center) is proud to be part of one of the most impactful cardiology congresses in the world. From advancing the management of complex bifurcation lesions and TAVI with Antoinette Neylon, to pioneering innovative approaches in the management and prediction of AMI with Pieter Smits, our relentless dedication to designing intelligent clinical trials and generating robust clinical evidence continues to shape and guide clinical practice. CERC Asia (Cardiovascular European Research Center Asia) #InterventionalCardiology Marie-Claude Morice Philippe Garot Dragica Paunovic Institut Cardiovasculaire Paris Sud (ICPS)

#ESC2024 Adjunct Pharmacology in PCI: Beyond Antiplatelet Therapy, the Next Chapter It was an honor to witness an impactful session co-chaired by J. Siller-Matula and our CEO, Marie-Claude Morice. The session brought together leading experts from around the globe to explore cutting-edge adjunct strategies in PCI. With thought-provoking presentations by esteemed speakers such as C. Michael Gibson, M.S., M.D., Marco Roffi, Kausik K. Ray, Davide Capodanno, and Renate Schnabel, the discussions underscored the commitment to further work to reach the excellence in improving patient care. We are proud to be part of a team that is shaping the future of Interventional Cardiology! #InterventionalCardiology #PatientCare #Innovation #ESC2024

Anticipating Great Learning at #ESCCongress 2024! 🌟 We are thrilled to share that our CERC (Cardiovascular European Research Center) directors and experts will be actively participating in selected sessions at the prestigious European Society of Cardiology (ESC) Congress 2024! 🚀 These sessions represent an incredible learning opportunity, bringing together cutting-edge research, innovative ideas, and the brightest minds in cardiology. 🩺💡 Our members are excited to dive into these impactful discussions and gain insights that will benefit our organization and elevate the standards of research and care we deliver. We look forward to these sessions as a platform for knowledge exchange, collaboration, and the chance to stay at the forefront of advancements in healthcare. Stay tuned as we share insights from #ESCCongress 2024 and highlight these impactful sessions—don’t miss out on the exciting learning opportunities ahead! Marie-Claude Morice, Pieter Smits, Antoinette Neylon, Davide Capodanno, Philippe Garot, Dragica Paunovic

👏 Congratulations to Biosensors International Group, Ltd on this incredible milestone! 🎉  CERC (Cardiovascular European Research Center) is proud to lead this exciting journey and drive its success. Together, we are advancing cardiovascular healthcare and improving clinical outcomes through pioneering technology. A big thank you to all participating sites and their management teams for achieving this milestone in advance and also to Biosensors International Team for this successful collaboration. #CardiovascularResearch #CERC #eUltra10k #BioFreedomUltra #Milestone #ClinicalResearch #Innovation

CERC is delighted to welcome Dr Jayesh J. from Advanced MedTech Solutions (AMS) at our Massy office. This visit was an excellent opportunity to discuss our ongoing projects and explore future prospects. We’re excited about the continued collaboration with AMS and the innovative advancements that lie ahead! Marie-Claude Morice Ute Windhövel PHANI KRISHNA KONDAMUDI (Il/Lui)

Congratulations, Dr. Roxana Mehran, on your appointment as Vice President of the American College of Cardiology (ACC) for 2025! This well-deserved recognition highlights your outstanding work, dedication, and leadership in cardiology. Your contributions to the field have been remarkable, demonstrating a true commitment to advancing cardiovascular health. The entire CERC team congratulates you on this achievement. It is always a pleasure to collaborate with such an esteemed colleague. We are confident that in this new role, starting in 2025, you will bring further innovations and progress to the ACC and the broader cardiology community. Congratulations, and best wishes for continued success! #Cardiology #HealthcareLeadership #ACC #InterventionalCardiology

🎉 Training Success! Enhancing Our Clinical Trial Expertise 🎉 We are thrilled to share the success of our recent training session with Prof.Davide Capodanno, focusing on key statistical concepts in clinical trials. This invaluable session was attended by all CERC Project Leaders and Clinical Operations Managers, who enthusiastically engaged in learning and discussions. 🔍 𝗧𝗼𝗽𝗶𝗰𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 1. Sample Size Determination: - Understanding its critical role in trial validity - Methods for accurate calculation - Implications on trial outcomes 2. Composite End Points: - Definition and practical examples - Advantages and challenges - Interpreting results effectively 3. Superiority and non-Inferiority Trials: - Key differences and purposes - Importance of statistical significance - Real-world case studies 💡 𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀 Sample Size: Ensures trials are adequately powered to detect true effects, minimizing errors. Composite End Points: Enhance trial efficiency but require careful interpretation. Superiority Trials: Demonstrate one treatment's superiority over another with statistical rigor. Inferiority Trials: Show new treatments are at least as effective as existing ones, ensuring clinical relevance. 🚀 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗔𝗽𝗽𝗿𝗲𝗰𝗶𝗮𝘁𝗶𝗼𝗻 The session saw enthusiastic participation from all attendees, fostering a deeper understanding of these essential statistical principles. We extend our heartfelt thanks to Prof. Davide Capodanno for his time and expertise. CERC is committed to ongoing learning initiatives to ensure our team remains at the forefront of clinical research methodologies. Stay tuned for more updates and future training sessions! #ClinicalTrials #StatisticalAnalysis #ProfessionalDevelopment #HealthcareResearch #CERC #LearningAndDevelopment #TeamExcellence